Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidder

By Syndicated Content Dec 11, 2022 | 2:44 PM

(Reuters) -French health group Sanofi said on Sunday that it no longer intends to make an offer for biotech company Horizon Therapeutics Plc , leaving Amgen Inc as the only remaining bidder.

The Wall Street Journal reported on Sunday that Amgen was in advanced talks to buy Horizon. A deal could be finalised by Monday assuming the talks with Amgen don’t fall apart, the report added.

(Reporting by Kanjyik Ghosh in BengaluruEditing by Peter Graff)

Juan Soto ghosted Yankees, jumped to Mets to 'grow a dynasty'

4h ago

Predators D Roman Josi (lower body) out vs. Stars

4h ago

White House releases strategy to counter anti-Muslim, anti-Arab hate

2h ago

Canada proposed $15 billion incentive to boost AI green data centre investment, Globe and Mail reports

2h ago

Soccer-Italy's Serie A does deal with Meta to fight illegal streaming

2h ago

Broadcom forecasts first-quarter revenue above estimates on strong AI chip demand

4h ago